Proteon Pharmaceuticals attracts environmental impact investment fund

October 24, 2017  – Proteon Pharmaceuticals S.A., a Polish biotechnology firm has signed an agreement with an international Investment Fund, the Aqua-Spark fund, which invests in sustainable aquaculture. Proteon Pharmaceuticals will use the funds to commercialize its products globally, develop production capacity and support the development of its bacteriophage-platform technology. Proteon Pharmaceuticals is a world […]

Read More